CLASS II Device recall · Reported 14 Aug 2019 · FDA Enforcement Report

MED EL Cochlear Implant System, PULSARci100 Standard recalled

Med-el Elektromedizinische Gereate is recalling MED EL Cochlear Implant System, PULSARci100 Standard, distributed nationwide in the US. The recall was initiated on 16 Oct 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesSerial Number 202001
Quantity recalled1 device

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2138-2019
FDA event ID
81683
Recalling firm
Med-el Elektromedizinische Gereate, Innsbruck, N/A
Classification
Class II
Status
Terminated
Recall initiated
16 Oct 2018
FDA classified
2 Aug 2019
Reported
14 Aug 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects
Device type
Hearing Aids

Timeline

16 Oct 2018Recall initiated by company
2 Aug 2019Classified by FDA+290 days
14 Aug 2019Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Devices were distributed despite the Helium-fine leak test results not being within the cochlear implant standards specification.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

MED EL Cochlear Implant System, PULSARci100 Standard - Product Usage: The PULSARci100 Implant is an implantable part of the MED EL Cochlear Implant System and can only be used together with compatible MED EL external components. The MED EL Cochlear Implant System is intended to evoke auditory sensations via electrical stimulation of the auditory pathways for severely to profoundly hearing impaired individuals who obtain little or no benefit from acoustic amplification in the best aided condition.

Where it was distributed

Worldwide distribution - US Nationwide in the states of California and Illinois. Countries of ARGENTINA, AUSTRALIA, AUSTRIA, BRAZIL, BULGARIA, CHINA, FRANCE, GEORGIA, KOREA, REPUBLIC OF, POLAND, RUSSIAN FEDERATION, SPAIN, SWEDEN.

Nationwide CaliforniaGeorgiaIllinois

Questions about this recall

Why was it recalled?

Devices were distributed despite the Helium-fine leak test results not being within the cochlear implant standards specification.

Which lots are affected?

Serial Number 202001

Where was it sold?

Worldwide distribution - US Nationwide in the states of California and Illinois. Countries of ARGENTINA, AUSTRALIA, AUSTRIA, BRAZIL, BULGARIA, CHINA, FRANCE, GEORGIA, KOREA, REPUBLIC OF, POLAND, RUSSIAN FEDERATION, SPAIN, SWEDEN.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 81683

This product is part of a recall event; the main page for the event is MED EL Cochlear Implant System, Mi1000 MED EL Concerto recalled.

More recalls from Med-el Elektromedizinische Gereate

All 5

Other Hearing Aids recalls

All 22